Department of Cardiology, Leeds General Infirmary, Leeds, UK.
Diab Vasc Dis Res. 2012 Jan;9(1):3-9. doi: 10.1177/1479164111427752. Epub 2011 Nov 8.
We investigated the association between diabetes mellitus (DM) and all-cause mortality in a large cohort of consecutive patients treated with primary percutaneous coronary intervention (PPCI) in the contemporary era.
We conducted a retrospective analysis of a single-centre registry of patients undergoing PPCI for ST-segment elevation myocardial infarction (STEMI) at a large regional PCI centre between 2005 and 2009. All-cause mortality in relation to patient and procedural characteristics was compared between patients with and without DM.
Of 2586 patients undergoing PPCI, 310 (12%) had DM. Patients with DM had a higher prevalence of multi-vessel coronary disease (p<0.001) and prior myocardial infarction (p<0.001). Patients with DM were less commonly admitted directly to the interventional centre (p=0.002). Symptom-to-balloon (p<0.001) and door-to-balloon time (p=0.002) were longer in patients with DM. Final infarct-related-artery TIMI-flow grade was lower in patients with DM (p=0.031). All-cause mortality at 30 days (p=0.0025) and 1 year (p<0.0001) was higher in patients with DM. DM was independently associated with increased mortality after multivariate adjustment for potential confounders.
Mortality remains substantially higher in patients with DM following reperfusion for STEMI in comparison with those without diabetes, despite contemporary management with PPCI. Greater co-morbidity, delayed presentation, longer times-to-reperfusion, and less optimal reperfusion may contribute to adverse outcomes.
我们研究了在当代经皮冠状动脉介入治疗(PPCI)治疗的大连续患者队列中,糖尿病(DM)与全因死亡率之间的关系。
我们对 2005 年至 2009 年期间在大型区域 PCI 中心接受 ST 段抬高型心肌梗死(STEMI)PPCI 的单中心登记处的患者进行了回顾性分析。比较了有和无 DM 患者之间与患者和手术特点相关的全因死亡率。
在 2586 例行 PPCI 的患者中,有 310 例(12%)患有 DM。DM 患者多支冠状动脉疾病的患病率较高(p<0.001)和既往心肌梗死(p<0.001)。DM 患者较少直接入住介入中心(p=0.002)。DM 患者的症状至球囊(p<0.001)和门至球囊时间(p=0.002)更长。DM 患者的最终梗死相关动脉 TIMI 血流分级较低(p=0.031)。DM 患者的 30 天(p=0.0025)和 1 年(p<0.0001)全因死亡率较高。在对潜在混杂因素进行多变量调整后,DM 与死亡率增加独立相关。
与没有糖尿病的患者相比,STEMI 再灌注后 DM 患者的死亡率仍然明显更高,尽管采用了当代的 PPCI 治疗。合并症更多、就诊延迟、再灌注时间延长和再灌注效果不理想可能导致不良结局。